vs

Side-by-side financial comparison of Navitas Semiconductor Corp (NVTS) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

Navitas Semiconductor Corp is the larger business by last-quarter revenue ($7.3M vs $3.9M, roughly 1.9× VSEE HEALTH, INC.). VSEE HEALTH, INC. runs the higher net margin — -200.0% vs -436.1%, a 236.1% gap on every dollar of revenue. On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -59.4%). VSEE HEALTH, INC. produced more free cash flow last quarter ($-1.9M vs $-8.2M). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs -43.9%).

Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

NVTS vs VSEE — Head-to-Head

Bigger by revenue
NVTS
NVTS
1.9× larger
NVTS
$7.3M
$3.9M
VSEE
Growing faster (revenue YoY)
VSEE
VSEE
+64.5% gap
VSEE
5.1%
-59.4%
NVTS
Higher net margin
VSEE
VSEE
236.1% more per $
VSEE
-200.0%
-436.1%
NVTS
More free cash flow
VSEE
VSEE
$6.2M more FCF
VSEE
$-1.9M
$-8.2M
NVTS
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
-43.9%
NVTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NVTS
NVTS
VSEE
VSEE
Revenue
$7.3M
$3.9M
Net Profit
$-31.8M
$-7.9M
Gross Margin
38.1%
46.7%
Operating Margin
-567.3%
-87.6%
Net Margin
-436.1%
-200.0%
Revenue YoY
-59.4%
5.1%
Net Profit YoY
20.2%
-144.7%
EPS (diluted)
$-0.14
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVTS
NVTS
VSEE
VSEE
Q4 25
$7.3M
$3.9M
Q3 25
$10.1M
$4.0M
Q2 25
$14.5M
$3.4M
Q1 25
$14.0M
$3.3M
Q4 24
$18.0M
$3.7M
Q3 24
$21.7M
$3.4M
Q2 24
$20.5M
$1.7M
Q1 24
$23.2M
$1.6M
Net Profit
NVTS
NVTS
VSEE
VSEE
Q4 25
$-31.8M
$-7.9M
Q3 25
$-19.2M
$-289.7K
Q2 25
$-49.1M
$-2.6M
Q1 25
$-16.8M
$-4.0M
Q4 24
$-39.9M
$-3.2M
Q3 24
$-18.7M
$-53.9M
Q2 24
$-22.3M
$-634.1K
Q1 24
$-3.7M
$62.8K
Gross Margin
NVTS
NVTS
VSEE
VSEE
Q4 25
38.1%
46.7%
Q3 25
37.9%
52.1%
Q2 25
16.1%
46.9%
Q1 25
37.9%
56.0%
Q4 24
12.4%
63.8%
Q3 24
39.7%
83.0%
Q2 24
39.0%
45.4%
Q1 24
41.1%
76.2%
Operating Margin
NVTS
NVTS
VSEE
VSEE
Q4 25
-567.3%
-87.6%
Q3 25
-192.0%
-51.7%
Q2 25
-149.4%
-66.5%
Q1 25
-180.5%
-55.1%
Q4 24
-216.9%
-81.1%
Q3 24
-133.6%
-1737.8%
Q2 24
-152.1%
-54.5%
Q1 24
-136.2%
6.4%
Net Margin
NVTS
NVTS
VSEE
VSEE
Q4 25
-436.1%
-200.0%
Q3 25
-190.2%
-7.3%
Q2 25
-338.7%
-77.1%
Q1 25
-120.1%
-119.2%
Q4 24
-221.7%
-85.9%
Q3 24
-86.4%
-1607.5%
Q2 24
-109.1%
-37.0%
Q1 24
-15.9%
3.9%
EPS (diluted)
NVTS
NVTS
VSEE
VSEE
Q4 25
$-0.14
$-0.31
Q3 25
$-0.09
$-0.02
Q2 25
$-0.25
$-0.16
Q1 25
$-0.09
$-0.24
Q4 24
$-0.22
$-1.96
Q3 24
$-0.10
$-3.58
Q2 24
$-0.12
$-0.12
Q1 24
$-0.02
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVTS
NVTS
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$236.9M
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$443.7M
$5.5M
Total Assets
$500.5M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVTS
NVTS
VSEE
VSEE
Q4 25
$236.9M
$5.3M
Q3 25
$150.6M
$472.8K
Q2 25
$161.2M
$291.6K
Q1 25
$75.1M
$410.1K
Q4 24
$86.7M
$326.1K
Q3 24
$98.3M
$2.3M
Q2 24
$111.7M
$1.1M
Q1 24
$128.9M
$724
Total Debt
NVTS
NVTS
VSEE
VSEE
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
NVTS
NVTS
VSEE
VSEE
Q4 25
$443.7M
$5.5M
Q3 25
$371.0M
$-5.6M
Q2 25
$388.9M
$-5.7M
Q1 25
$341.8M
$-3.5M
Q4 24
$348.0M
$-18.5K
Q3 24
$380.8M
$933.1K
Q2 24
$388.1M
$53.1M
Q1 24
$397.9M
$-13.2M
Total Assets
NVTS
NVTS
VSEE
VSEE
Q4 25
$500.5M
$22.4M
Q3 25
$430.2M
$18.7M
Q2 25
$449.4M
$18.2M
Q1 25
$370.8M
$19.4M
Q4 24
$390.0M
$20.0M
Q3 24
$419.4M
$22.3M
Q2 24
$439.1M
$78.6M
Q1 24
$467.9M
$1.4M
Debt / Equity
NVTS
NVTS
VSEE
VSEE
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVTS
NVTS
VSEE
VSEE
Operating Cash FlowLast quarter
$-8.1M
$-1.9M
Free Cash FlowOCF − Capex
$-8.2M
$-1.9M
FCF MarginFCF / Revenue
-111.8%
-49.2%
Capex IntensityCapex / Revenue
0.7%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-44.4M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVTS
NVTS
VSEE
VSEE
Q4 25
$-8.1M
$-1.9M
Q3 25
$-10.0M
$-754.5K
Q2 25
$-11.2M
$-324.6K
Q1 25
$-13.5M
$-440.5K
Q4 24
$-10.2M
$-3.0M
Q3 24
$-13.7M
$-221.0K
Q2 24
$-15.1M
$-3.2M
Q1 24
$-19.8M
$579.3K
Free Cash Flow
NVTS
NVTS
VSEE
VSEE
Q4 25
$-8.2M
$-1.9M
Q3 25
$-10.7M
$-761.8K
Q2 25
$-11.9M
$-328.2K
Q1 25
$-13.6M
$-452.4K
Q4 24
$-10.8M
$-3.0M
Q3 24
$-14.3M
$-226.0K
Q2 24
$-17.9M
$-3.2M
Q1 24
$-22.7M
$570.5K
FCF Margin
NVTS
NVTS
VSEE
VSEE
Q4 25
-111.8%
-49.2%
Q3 25
-106.1%
-19.1%
Q2 25
-82.2%
-9.7%
Q1 25
-96.8%
-13.6%
Q4 24
-59.8%
-79.8%
Q3 24
-65.9%
-6.7%
Q2 24
-87.3%
-187.6%
Q1 24
-97.9%
35.2%
Capex Intensity
NVTS
NVTS
VSEE
VSEE
Q4 25
0.7%
0.2%
Q3 25
7.0%
0.2%
Q2 25
4.7%
0.1%
Q1 25
0.3%
0.4%
Q4 24
3.1%
0.1%
Q3 24
2.6%
0.1%
Q2 24
13.4%
2.1%
Q1 24
12.5%
0.5%
Cash Conversion
NVTS
NVTS
VSEE
VSEE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
9.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NVTS
NVTS

Segment breakdown not available.

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons